Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00887315 | The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)(SMART) | terminated | Phase 2 | 11 | University of ChicagoOTHER | 1 | Dec 6, 2013 | clinicaltrials |
| NCT01561456 | Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung | completed | Phase 2 | 100 | Axelar ABINDUSTRY | 5 | Dec 5, 2013 |
| NCT00003562 | Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 2 | 38 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003583 | Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer | unknown | Phase 2 | 20 | University of FloridaOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00004264 | Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00004265 | Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer | unknown | Phase 2 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005872 | Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00701870 | Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer | terminated | Phase 2 | 1 | TelikINDUSTRY | 1 | Nov 27, 2013 | clinicaltrials |
| NCT00004160 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed | completed | Phase 1 / Phase 2 | 72 | University of Alabama at BirminghamOTHER | 1 | Nov 26, 2013 | clinicaltrials |
| NCT00062439 | S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors | completed | Phase 2 | 46 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01504542 | Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer | withdrawn | Phase 2 | 0 | Heat BiologicsINDUSTRY | 1 | Nov 21, 2013 | clinicaltrials |
| NCT00004159 | Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor | terminated | Phase 1 / Phase 2 | 54 | University of Alabama at BirminghamOTHER | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00002577 | Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 19, 2013 | clinicaltrials |
| NCT01027676 | Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC) | unknown | Phase 1 / Phase 2 | 50 | National Cancer Center, KoreaOTHER_GOV | 1 | Nov 14, 2013 | clinicaltrials |
| NCT00600821 | A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. | completed | Phase 2 | 118 | PfizerINDUSTRY | 6 | Nov 8, 2013 | clinicaltrials |
| NCT00003090 | Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer | unknown | Phase 2 | 30 | Cancer Biotherapy Research GroupOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00064064 | 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | — | Vion PharmaceuticalsINDUSTRY | 2 | Nov 6, 2013 | clinicaltrials |
| NCT00077246 | ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00104780 | Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | unknown | Phase 2 | — | EpimmuneINDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00282022 | VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | completed | Phase 2 | 87 | Vion PharmaceuticalsINDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00828841 | Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC | completed | Phase 2 | 601 | Accelerated Community Oncology Research NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01528488 | Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC | completed | Phase 2 / Phase 3 | 118 | Sun Yat-sen UniversityOTHER | 1 | Nov 5, 2013 | clinicaltrials |
| NCT00365183 | Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer | terminated | Phase 2 | 74 | Pharmacyclics LLC.INDUSTRY | 1 | Oct 31, 2013 | clinicaltrials |
| NCT00101413 | BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC) | completed | Phase 2 | 52 | BayerINDUSTRY | 2 | Oct 30, 2013 | clinicaltrials |
| NCT00147537 | Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer | completed | Phase 1 / Phase 2 | 282 | PfizerINDUSTRY | 4 | Oct 30, 2013 | clinicaltrials |
| NCT01533233 | Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients | unknown | Phase 1 / Phase 2 | 100 | National Taiwan University HospitalOTHER | 1 | Oct 29, 2013 | clinicaltrials |
| NCT00413283 | Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 63 | AmgenINDUSTRY | 8 | Oct 24, 2013 | clinicaltrials |
| NCT01674738 | TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV(SELECT-A) | withdrawn | Phase 2 | 0 | Aktion Bronchialkarzinom e.V.OTHER | 0 | Oct 11, 2013 | clinicaltrials |
| NCT00052949 | Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 91 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01086254 | SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer | completed | Phase 2 | 119 | SanofiINDUSTRY | 5 | Sep 24, 2013 | clinicaltrials |
| NCT00022009 | Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00003847 | VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer | terminated | Phase 2 | 36 | Vertex Pharmaceuticals IncorporatedINDUSTRY | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00385398 | QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC | withdrawn | Phase 2 | 0 | University of Medicine and Dentistry of New JerseyOTHER | 0 | Sep 2, 2013 | clinicaltrials |
| NCT01075399 | Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors(HX4-200) | completed | Phase 2 | 50 | Siemens Molecular ImagingINDUSTRY | 0 | Aug 30, 2013 | clinicaltrials |
| NCT01368848 | Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) | completed | Phase 2 | 7 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT01932229 | An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib | unknown | Phase 2 | 20 | Sheba Medical CenterOTHER_GOV | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00406276 | Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 28 | Emory UniversityOTHER | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00922584 | Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor | completed | Phase 2 | 65 | Chinese Society of Lung CancerOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT01926483 | Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection(ZTOG-1202) | unknown | Phase 2 | 75 | Zhejiang Cancer HospitalOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT00006470 | Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Aug 13, 2013 | clinicaltrials |
| NCT00398385 | Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer | unknown | Phase 2 | 170 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00616031 | Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 150 | Kyoto UniversityOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01024712 | Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer | unknown | Phase 2 | 26 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00583830 | A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 111 | Human Genome Sciences Inc.INDUSTRY | 4 | Aug 8, 2013 | clinicaltrials |
| NCT00092924 | Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | Human Genome Sciences Inc.INDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01914458 | Image Discovering Early Lung Cancer Project(IDEALCAP) | unknown | Phase 2 | 600 | Cathay General HospitalOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00585533 | A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 40 | University of UtahOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00003111 | Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | completed | Phase 2 | 10 | Yale UniversityOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT01728181 | A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation | withdrawn | Phase 1 / Phase 2 | 0 | University of UtahOTHER | 0 | Jul 25, 2013 | clinicaltrials |
| NCT00072059 | Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Dec 6, 2013source: clinicaltrials